NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s leading issuers of crypto exchange-traded funds (ETFs), today announced the launch of the 21shares Polkadot ETF (TDOT), which ...

The standard Nothing Phone 4a features a redesigned Glyph Bar comprising 63 mini-LEDs arranged in 7 square light zones. Nothing has released two midrange phones for the mass-centric market – Phone 4a ...

Quantum dots (QDs) are semiconducting nanoparticles with distinct optical and electrical properties that fall between bulk materials and discrete molecules. QDs' size-dependent tunability makes them ...

Department of Transportation leaders have told employees they are integrating Google's Gemini AI model into rule writing. Staffers were told a draft FAA rule was already written with Gemini. Critics ...

If you're an American and you leave your house, you probably interface with something touched by the Department of Transportation (DOT). Cars, planes, and public transit all fall under the massive ...

LAS VEGAS--(BUSINESS WIRE)--Dot Ai (Nasdaq: DAIC) (“Dot Ai” or the “Company”), an IoT and AI-based SaaS company redefining asset intelligence for industrial technology, today announced it will ...

Soon, the safety regulations that keep airplanes in the sky, car passengers safe, and prevent gas pipelines from exploding, might be written by AI. This concerns some people in the Transportation ...

The Echo Dot is one of Amazon's most affordable smart hubs, and while it doesn't pack the most powerful speaker and isn't as feature-rich as the Echo Studio, it's a neat little way to enjoy the Alexa ...

Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...